CHEMBL3265323 [210970]
CHEMBL3265323
| SMILES | C=CCN1CCCC1CNC(=O)c1cc(CCCSC2CC(=O)N(CCCCCC(=O)NC(C(=O)NC(Cc3ccccc3)C(=O)NC(Cc3ccccc3)C(=O)NC(Cc3ccc(O)cc3)C(=O)NCC(=O)NCC(=O)NC(CO)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)NC(CCCCNC(=O)CN3CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC3)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(N)=O)C(=O)NC(CC(N)=O)C(=O)NC(Cc3ccccc3)C(=O)NC(CCCC[n+]3c(C)cc(C=CC=Cc4ccc(N(C)C)cc4)cc3C)C(=O)NC(C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(Cc3ccc(O)cc3)C(=O)O)C(C)O)C(C)O)C2=O)cc(OC)c1OC |
| InChIKey | CZDGXTCLWDUEJD-UHFFFAOYSA-O |
Chemical Properties
| Hydrogen bond acceptors | None |
| Hydrogen bond donors | None |
| Rotatable bonds | None |
| Log P | None |
| Molecular weight (Da) | None |
Database connections
|
|
No bioactivity data available.
CHEMBL3265323
Drug properties
| Molecular type | Small molecule |
| Physiological/Surrogate | Surrogate |
| Approved drug | No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0
Database connections
|
|